Synergic Effect of the Antimicrobial Peptide ToAP2 and Fluconazole on Candida albicans Biofilms

Author:

do Nascimento Dias Jhones1ORCID,Hurtado Erazo Fabián Andrés1ORCID,Bessa Lucinda J.2ORCID,Eaton Peter23ORCID,Leite José Roberto de Souza de Almeida4ORCID,Paes Hugo Costa5,Nicola André Moraes5ORCID,Silva-Pereira Ildinete1ORCID,Albuquerque Patrícia1ORCID

Affiliation:

1. Laboratory of Molecular Biology of Fungi, University of Brasilia, Brasilia 70910-900, Brazil

2. LAQV/REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal

3. The Bridge, School of Chemistry, University of Lincoln, Lincoln LN6 7TS, UK

4. Center for Research in Applied Morphology and Immunology, NuPMIA, University of Brasilia, Brasilia 70910-900, Brazil

5. Faculty of Medicine, University of Brasilia, Brasilia 70910-900, Brazil

Abstract

Candida albicans is one of the agents of invasive candidiasis, a life-threatening disease strongly associated with hospitalization, particularly among patients in intensive care units with central venous catheters. This study aimed to evaluate the synergistic activity of the antifungal peptide ToAP2 combined with fluconazole against C. albicans biofilms grown on various materials. We tested combinations of different concentrations of the peptide ToAP2 with fluconazole on C. albicans biofilms. These biofilms were generated on 96-well plates, intravenous catheters, and infusion tubes in RPMI medium at two maturation stages. Scanning electron microscopy and atomic force microscopy were employed to assess the biofilm structure. We also evaluated the expression of genes previously proven to be involved in C. albicans biofilm formation in planktonic and biofilm cells after treatment with the peptide ToAP2 using qPCR. ToAP2 demonstrated a synergistic effect with fluconazole at concentrations up to 25 µM during both the early and mature stages of biofilm formation in 96-well plates and on medical devices. Combinations of 50, 25, and 12.5 µM of ToAP2 with 52 µM of fluconazole significantly reduced the biofilm viability compared to individual treatments and untreated controls. These results were supported by substantial structural changes in the biofilms observed through both scanning and atomic force microscopy. The gene expression analysis of C. albicans cells treated with 25 µM of ToAP2 revealed a decrease in the expression of genes associated with membrane synthesis, along with an increase in the expression of genes involved in efflux pumps, adhesins, and filamentation. Our results highlight the efficacy of the combined ToAP2 and fluconazole treatment against C. albicans biofilms. This combination not only shows therapeutic potential but also suggests its utility in developing preventive biofilm tools for intravenous catheters.

Funder

National Council for Scientific and Technological Development

Fundação de Apoio à Pesquisa do Distrito Federal

Publisher

MDPI AG

Reference61 articles.

1. Candidiasis: Predisposing factors, prevention, diagnosis and alternative treatment;Martins;Mycopathologia,2014

2. Candida albicans Biofilms and Human Disease;Nobile;Annu. Rev. Microbiol.,2015

3. Candida albicans cell-type switching and functional plasticity in the mammalian host;Noble;Nat. Rev. Microbiol.,2017

4. Growth of Candida albicans hyphae;Sudbery;Nat. Rev. Microbiol.,2011

5. World Health Organization (2022). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, World Health Organization.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3